Aquestive Sale Purchase Of Stock vs Depreciation Analysis

AQST Stock  USD 3.82  0.07  1.80%   
Aquestive Therapeutics financial indicator trend analysis is way more than just evaluating Aquestive Therapeutics prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Aquestive Therapeutics is a good investment. Please check the relationship between Aquestive Therapeutics Sale Purchase Of Stock and its Depreciation accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aquestive Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Aquestive Stock please use our How to Invest in Aquestive Therapeutics guide.

Sale Purchase Of Stock vs Depreciation

Sale Purchase Of Stock vs Depreciation Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Aquestive Therapeutics Sale Purchase Of Stock account and Depreciation. At this time, the significance of the direction appears to have no relationship.
The correlation between Aquestive Therapeutics' Sale Purchase Of Stock and Depreciation is 0.05. Overlapping area represents the amount of variation of Sale Purchase Of Stock that can explain the historical movement of Depreciation in the same time period over historical financial statements of Aquestive Therapeutics, assuming nothing else is changed. The correlation between historical values of Aquestive Therapeutics' Sale Purchase Of Stock and Depreciation is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Sale Purchase Of Stock of Aquestive Therapeutics are associated (or correlated) with its Depreciation. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Depreciation has no effect on the direction of Sale Purchase Of Stock i.e., Aquestive Therapeutics' Sale Purchase Of Stock and Depreciation go up and down completely randomly.

Correlation Coefficient

0.05
Relationship DirectionPositive 
Relationship StrengthInsignificant

Sale Purchase Of Stock

Depreciation

Depreciation indicates how much of Aquestive Therapeutics value has been used up. For tax purposes Aquestive Therapeutics can deduct the cost of the tangible assets it purchases as business expenses. However, Aquestive Therapeutics must depreciate these assets in accordance with IRS rules about how and when the deduction may be taken, and how long it will last. The systematic allocation of the cost of a tangible asset over its useful life.
Most indicators from Aquestive Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Aquestive Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Aquestive Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state.
For more information on how to buy Aquestive Stock please use our How to Invest in Aquestive Therapeutics guide.At this time, Aquestive Therapeutics' Selling General Administrative is comparatively stable compared to the past year. Tax Provision is likely to gain to about 257.2 K in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 8.5 M in 2024.
 2021 2022 2023 2024 (projected)
Gross Profit35.8M28.3M29.8M31.9M
Total Revenue50.8M47.7M50.6M48.2M

Aquestive Therapeutics fundamental ratios Correlations

0.770.76-0.220.29-0.380.880.960.230.640.270.580.57-0.490.99-0.44-0.34-0.82-0.340.30.88-0.79-0.670.04-0.8-0.55
0.770.82-0.67-0.07-0.740.510.670.710.380.080.620.87-0.530.72-0.47-0.14-0.87-0.640.680.6-0.87-0.870.25-0.49-0.03
0.760.82-0.530.01-0.570.730.750.50.32-0.130.740.76-0.380.74-0.370.02-0.77-0.420.520.69-0.75-0.740.39-0.52-0.26
-0.22-0.67-0.530.560.980.0-0.12-0.460.010.09-0.63-0.870.37-0.170.33-0.430.590.63-0.97-0.080.610.77-0.710.0-0.33
0.29-0.070.010.560.520.310.5-0.09-0.09-0.28-0.32-0.34-0.540.38-0.44-0.01-0.25-0.24-0.40.63-0.170.0-0.51-0.56-0.54
-0.38-0.74-0.570.980.52-0.12-0.25-0.43-0.16-0.06-0.67-0.910.4-0.320.34-0.30.670.61-0.96-0.180.690.82-0.660.11-0.21
0.880.510.730.00.31-0.120.89-0.050.540.110.630.33-0.260.88-0.32-0.29-0.56-0.050.070.82-0.58-0.40.09-0.79-0.62
0.960.670.75-0.120.5-0.250.890.180.510.040.50.45-0.60.98-0.58-0.2-0.81-0.410.220.98-0.79-0.650.02-0.86-0.63
0.230.710.5-0.46-0.09-0.43-0.050.180.07-0.120.110.58-0.270.19-0.24-0.11-0.45-0.560.380.15-0.42-0.550.030.060.26
0.640.380.320.01-0.09-0.160.540.510.070.750.220.230.130.630.03-0.72-0.260.15-0.060.36-0.22-0.3-0.14-0.17-0.58
0.270.08-0.130.09-0.28-0.060.110.04-0.120.750.020.060.330.230.48-0.720.040.38-0.15-0.110.150.05-0.320.12-0.26
0.580.620.74-0.63-0.32-0.670.630.50.110.220.020.79-0.210.54-0.280.11-0.57-0.260.610.4-0.66-0.570.7-0.44-0.13
0.570.870.76-0.87-0.34-0.910.330.450.580.230.060.79-0.440.52-0.390.13-0.77-0.630.830.37-0.79-0.860.61-0.250.03
-0.49-0.53-0.380.37-0.540.4-0.26-0.6-0.270.130.33-0.21-0.44-0.540.8-0.410.830.89-0.53-0.710.770.72-0.080.620.21
0.990.720.74-0.170.38-0.320.880.980.190.630.230.540.52-0.54-0.48-0.31-0.81-0.360.250.92-0.78-0.660.02-0.81-0.63
-0.44-0.47-0.370.33-0.440.34-0.32-0.58-0.240.030.48-0.28-0.390.8-0.48-0.330.660.82-0.45-0.680.770.68-0.320.550.26
-0.34-0.140.02-0.43-0.01-0.3-0.29-0.2-0.11-0.72-0.720.110.13-0.41-0.31-0.33-0.14-0.460.49-0.05-0.13-0.210.550.060.26
-0.82-0.87-0.770.59-0.250.67-0.56-0.81-0.45-0.260.04-0.57-0.770.83-0.810.66-0.140.78-0.69-0.810.950.92-0.240.680.27
-0.34-0.64-0.420.63-0.240.61-0.05-0.41-0.560.150.38-0.26-0.630.89-0.360.82-0.460.78-0.71-0.50.770.84-0.30.320.0
0.30.680.52-0.97-0.4-0.960.070.220.38-0.06-0.150.610.83-0.530.25-0.450.49-0.69-0.710.21-0.71-0.80.65-0.190.3
0.880.60.69-0.080.63-0.180.820.980.150.36-0.110.40.37-0.710.92-0.68-0.05-0.81-0.50.21-0.78-0.640.0-0.87-0.64
-0.79-0.87-0.750.61-0.170.69-0.58-0.79-0.42-0.220.15-0.66-0.790.77-0.780.77-0.130.950.77-0.71-0.780.9-0.40.720.19
-0.67-0.87-0.740.770.00.82-0.4-0.65-0.55-0.30.05-0.57-0.860.72-0.660.68-0.210.920.84-0.8-0.640.9-0.440.40.2
0.040.250.39-0.71-0.51-0.660.090.020.03-0.14-0.320.70.61-0.080.02-0.320.55-0.24-0.30.650.0-0.4-0.440.020.12
-0.8-0.49-0.520.0-0.560.11-0.79-0.860.06-0.170.12-0.44-0.250.62-0.810.550.060.680.32-0.19-0.870.720.40.020.37
-0.55-0.03-0.26-0.33-0.54-0.21-0.62-0.630.26-0.58-0.26-0.130.030.21-0.630.260.260.270.00.3-0.640.190.20.120.37
Click cells to compare fundamentals

Aquestive Therapeutics Account Relationship Matchups

Aquestive Therapeutics fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets78.5M62.9M62.0M55.7M57.4M57.8M
Other Current Liab5.5M9.7M9.6M8.8M7.1M6.8M
Total Current Liabilities18.6M21.1M22.0M39.7M18.3M20.0M
Total Stockholder Equity(6.1M)(48.5M)(82.1M)(118.6M)(106.5M)(101.2M)
Net Tangible Assets(6.3M)(48.6M)(82.2M)(120.0M)(108.0M)(102.6M)
Retained Earnings(130.5M)(186.3M)(256.8M)(311.2M)(319.1M)(303.1M)
Accounts Payable12.3M7.1M8.3M9.9M8.9M9.4M
Cash49.3M31.8M28.0M27.3M23.9M29.0M
Other Assets286K7.8M6.9M6.5M1.00.95
Long Term Debt60.3M34.3M51.6M33.4M27.5M41.5M
Net Receivables13.1M7.0M12.1M4.7M8.5M7.7M
Inventory2.9M2.5M4.0M5.8M6.8M3.9M
Total Liab84.6M111.4M144.1M174.2M163.9M98.0M
Total Current Assets68.3M44.6M47.3M39.9M41.0M42.4M
Intangible Assets153K102K51K1.4M1.3M1.3M
Common Stock34K35K41K55K69K65.6K
Property Plant Equipment9.7M6.9M5.1M7.9M7.1M7.7M
Other Liab5.7M53.1M68.7M97.6M112.2M117.8M
Cash And Short Term Investments49.3M31.8M28.0M27.3M23.9M32.1M
Short Long Term Debt Total60.3M40.5M56.4M56.1M33.3M49.9M
Property Plant And Equipment Net9.7M10.3M7.8M7.9M9.7M8.6M
Current Deferred Revenue806K693K765K1.5M1.6M1.1M
Net Debt11.0M8.7M28.4M28.8M9.4M13.1M
Non Current Assets Total10.2M18.3M14.7M15.8M16.5M16.4M
Non Currrent Assets Other286K7.8M6.9M6.5M5.4M4.0M
Common Stock Shares Outstanding25.4M33.7M38.1M48.7M61.3M37.4M
Liabilities And Stockholders Equity78.5M62.9M62.0M55.7M57.4M66.8M
Non Current Liabilities Total66.0M90.3M122.2M134.6M145.6M96.6M
Other Current Assets3.0M6.8M6.2M2.1M1.9M3.0M
Other Stockholder Equity124.3M137.7M174.6M192.6M212.5M142.2M
Property Plant And Equipment Gross9.7M10.3M7.8M7.9M52.6M55.3M
Net Invested Capital54.2M(11.6M)(28.6M)(66.4M)(79.0M)(75.0M)
Net Working Capital49.8M23.5M25.3M209K22.7M20.1M

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas  

Additional Tools for Aquestive Stock Analysis

When running Aquestive Therapeutics' price analysis, check to measure Aquestive Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aquestive Therapeutics is operating at the current time. Most of Aquestive Therapeutics' value examination focuses on studying past and present price action to predict the probability of Aquestive Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aquestive Therapeutics' price. Additionally, you may evaluate how the addition of Aquestive Therapeutics to your portfolios can decrease your overall portfolio volatility.